Enanta Pharmaceuticals, Inc.

ENTA · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$32,298$44,812$60,213$84,349
Short-Term Investments$156,566$159,299$133,162$132,342
Receivables$6,882$8,357$40,628$40,162
Inventory$0$0$0$0
Other Curr. Assets$8,590$10,240$8,857$11,292
Total Curr. Assets$204,336$222,708$242,860$268,145
Property Plant & Equip (Net)$72,944$74,867$76,675$77,043
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$3,360$3,360$0$0
Tax Assets$0$0$0$0
Other NC Assets$92$94$3,458$3,454
Total NC Assets$76,396$78,321$80,133$80,497
Other Assets$0$0$0$0
Total Assets$280,732$301,029$322,993$348,642
Liabilities
Payables$1,948$3,547$4,756$4,726
Short-Term Debt$33,856$30,149$32,877$33,749
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$12,751$10,853$8,314$10,575
Total Curr. Liab.$48,555$44,549$45,947$49,050
LT Debt$167,200$176,949$183,265$187,541
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$260$252$243$235
Total NC Liab.$167,460$177,201$183,508$187,776
Other Liabilities$0$0$0$0
Cap. Leases$54,757$55,656$58,732$57,459
Total Liabilities$216,015$221,750$229,455$236,826
Equity
Pref Stock$0$0$0$0
Common Stock$214$214$214$213
Retained Earnings-$404,929-$386,229-$367,974-$345,330
AOCI-$339-$402-$224-$29
Other Equity$469,771$465,696$461,522$456,962
Total Equity$64,717$79,279$93,538$111,816
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$280,732$301,029$322,993$348,642
Net Debt$168,758$162,286$155,929$136,941